Results
CORONA Remedies Q2 FY27 Revenue Up 22.2% YoY
CORONA Remedies reported Q2 FY27 revenue of ₹441.2 Cr, up 22.2% YoY, with PAT at ₹60.3 Cr.
India business contributed 97.1% of H1 revenue, with chronic therapies representing 72.1% of portfolio.
Compa
